Polymorphisms in the RANTES gene increase susceptibility to active tuberculosis in Tunisia

DNA and Cell Biology

Volumn 30, Issue 10, 2011, Pages 789-800

  Ben Selma, Walid ^a   Harizi, Hedi ^b   Bougmiza, Iheb ^c   Kahla, Imen Ben ^a   Letaief, Mahmoud ^a   Boukadida, Jalel ^a  

^a FARHAT HACHED HOSPITAL   (Tunisia)

^b CNRS   (France)

^c Department of Community Medicine ^*  (Tunisia)

Author keywords

[No Author keywords available]

Indexed keywords

RANTES;

ADULT; ALLELE; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE PREDISPOSITION; EXTRAPULMONARY TUBERCULOSIS; FEMALE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HUMAN; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK; TUNISIA;

ADULT; AGED; ALLELES; CASE-CONTROL STUDIES; CHEMOKINE CCL5; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; MUTATION; ODDS RATIO; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RISK FACTORS; TUBERCULOSIS, PULMONARY; TUNISIA;

MYCOBACTERIUM TUBERCULOSIS;

EID: 80053533757     PISSN: 10445498     EISSN: 15577430     Source Type: Journal    
DOI: 10.1089/dna.2010.1200     Document Type: Article

References (52)

1. Bacon, K.B., Premack, B.A., Gardner P., and Schall, T.J. (1995). Activation of dual T cell signaling pathways by the chemokine RANTES. Science 269, 1727-1730.
2. Bellamy, R. (2003). Susceptibility to mycobacterial infections: the importance of host genetics. Genes Immun 4, 4-11. (Pubitemid 38967569)
3. Ben Selma, W., Harizi, H., Bougmiza, I., Hannachi, N., Ben Kahla, I., Zaieni, R., and Boukadida, J. (2011). IFN-g p874T/A polymorphism is associated with susceptibility to active pulmonary tuberculosis development in Tunisian patients. DNA Cell Biol, DOI:10.1089/dna.2010.1157.
4. Bonn, D. (1999). International consortium SN(i)Ps away at individuality. Lancet 353, 1684.
5. Cambien, F., Poirier, O., Nicaud, V., Herrmann, S.M., Mallet, C., Ricard, S., Behague, I., Hallet, V., Blanc, H., Loukaci, V., Thillet, J., Evans, A., Ruidavets, J.B., Arveiler, D., Luc, G., and Tiret, L. (1999). Sequence diversity in 36 candidate genes for cardiovascular disorders. Am J Hum Genet 65, 183-191. (Pubitemid 30470463)
6. Cargill, M., Altshuler, D., Ireland, J., Sklar, P., Ardlie, K., Patil, N., Shaw, N., Lane, C.R., Lim, E.P., Kalyanaraman, N., Nemesh, J., Friedland, L., Rolfe, A., Warrington, J., Lipshutz, R., Daley, G.Q., and Lander, E.S. (1999). Characterization of single-nucleotide polymorphisms in coding regions of human genes. Nat Genet 22, 231-238. (Pubitemid 29297248)
7. Casanova, J.L., and Abel, L. (2004). The human model: a genetic dissection of immunity to infection in natural conditions. Nat Rev Immunol 4, 55-66. (Pubitemid 38084132)
8. Chensue, S.W., Warmington, K., Ruth, J.H., Lukacs, N., and Kunkel, S.L. (1997). Mycobacterial and schistosomal antigen-elicited granuloma formation in IFN-gamma and IL-4 knockout mice: analysis of local and regional cytokine and chemokine networks. J Immunol 159, 3565-3573. (Pubitemid 127482116)
9. Chensue, S.W., Warmington, K.S., Allenspach, E.J., Lu, B., Gerard, C., Kunkel, S.L., and Lukacs, N.W. (1999). Differential expression and cross-regulatory function of RANTES during mycobacterial (type 1) and schistosomal (type 2) antigen elicited granulomatous inflammation. J Immunol 163, 165-173. (Pubitemid 29295838)
10. Chu, S.F., Tam, C.M., Wong, H.S., Kam, K.M., Lau, Y.L., and Chiang, A.K. (2007). Association between RANTES functional polymorphisms and tuberculosis in Hong Kong Chinese. Genes and Immunity 8, 475-479. (Pubitemid 47365613)
11. Coelho, A.L., Hogaboam, C.M., and Kunkel, S.L. (2005). Chemokines provide the sustained inflammatory bridge between innate and acquired immunity. Cytokine Growth Factor Rev 116, 553-560. (Pubitemid 41505516)
12. Cooke, G.S., and Hill, A.V. (2001). Genetics of susceptibility to human infectious disease. Nat Rev Genet 2, 967-977. (Pubitemid 33691093)
13. Devergne, O., Marfaing-Koka, A., Schall, T.J., Leger-Ravet, .B., Sadick, M., Peuchmaur, M., Crevon, M.C., Kim, T., Galanaud, P., and Emilie, D. (1994). Production of the RANTES chemokine in delayed-type hypersensitivity reactions: involvement of macrophages and endothelial cells. J Exp Med 179, 189-1694.
14. Dorner, B.G., Scheffold, A., Rolph, M.S., Huser, M.B., aufmann, S.H., Radbruch, A., Flesch, I.E., Kroczek, R.A. (2002). IP- 1alpha, MIP-1beta, RANTES, and ATAC/lymphotactin function together with IFN-gamma as type 1 cytokines. Proc Natl Acad Sci USA 99, 6181-6186.
15. Fahey, T.J., Tracey, K.J., Tekamp-Olson, P., Cousens, L.S., Jones, W.G., Shires, G.T., Cerami, A., and Sherry, B. (1992). Macrophage inflammatory protein-1 modulates macrophages function. J Immunol 148, 2764-2769.
16. Flores-Villanueva, P.O., Ruiz-Morales, J.A., Song, C.H., Flores, L.M., Jo, E.K., Montañ o, M., Barnes, P.F., Selman, M., and Granados, J. (2005). A functional promoter polymorphism in monocyte chemoattractant protein-1 is associated with increased susceptibility to pulmonary tuberculosis. J Exp Med 202, 1649-1658. (Pubitemid 41815871)
17. Fryer, A.A., Spiteri, M.A., Bianco, A., Hepple, M., Jones, P.W., Strange, R.C., Makki, R., Tavernier, G., Smilie, F.I., Custovic, A., Woodcock, A.A., Ollier, W.E., and Hajeer, A.H. (2000). The-403 G?A promoter polymorphism in the RANTES gene is associated with atopy and asthma. Genes Immun 1, 509-514.
18. Gaunt, T.R., Rodriguez, S., and Day, I.N. (2007). Cubic exact solutions for the estimation of pairwise haplotype frequencies: implications for linkage disequilibrium analyses and a web tool 'CubeX'. BMC Bioinformatics 8, 428-436.
19. Haliassos, A., Chomel, J.C., Tesson, L., Baudis, M., Kruh, J., Kaplan, J.C., and Kitzis, A. (1989). Modification of enzymatically amplified DNA for the detection of point mutations. Nucleic Acids Res 17, 3606. (Pubitemid 19120470)
20. Hizawa, N., Yamaguchi, E., Konno, S., Tanino, Y., Jinushi, E., and Nishimura, M. (2002). A functional polymorphism in the RANTES gene promoter is associated with the development of late-onset asthma. Am J Respir Crit Care Med 166, 686-690. (Pubitemid 34971851)
21. Jamieson, S.E., Miller, E.N., Black, G.F., Peacock, C.S., Cordell, H.J., Howson, J.M., Shaw, M.A., Burgner, D., Xu, W., Lins- Lainson, Z., Shaw, J.J., Ramos, F., Silveira, F., and Blackwell, J.M. (2004). Evidence for a cluster of genes on chromosome 17q11-q21 controlling susceptibility to tuberculosis and leprosy in Brazilians. Genes Immun 5, 46-57. (Pubitemid 38967629)
22. Jo, E.K., Park, J.K., and Dockrell, H.M. (2003). Dynamics of cytokine generation in patients with active pulmonary tuberculosis. Curr Opin Infect Dis 16, 205-210. (Pubitemid 36677313)
23. Kruglyak, L. (1997). The use of a genetic map of biallelic markers in linkage studies. Nat Genet 17, 21-24. (Pubitemid 27377527)
24. Kurashima, K., Mukaida, N., Fujimura, M., Yasui, M., Nakazumi, Y., Matsuda, T., and Matsushima, K. (1997). Elevated chemokine levels in bronchoalveolar lavage fluid of tuberculosis patients. Am J Respir Crit Care Med 155, 1474-1477. (Pubitemid 27172801)
25. Landegren, U., Nilsson, M., and Kwok, P.Y. (1998). Reading bits of genetic information: methods for single-nucleotide polymorphism analysis. Genome Res 8, 769-776. (Pubitemid 28458279)
26. Lima, M.F., Zhang, Y., and Villalta, F. (1997). Beta-chemokines that inhibit HIV-1 infection of human macrophages stimulate uptake and promote destruction of Trypanosoma cruzi by human macrophages. Cell Mol Biol 43, 1067-1076.
27. Liu, H., Chao, D., Nakayama, E.E., Taguchi, H., Goto, M., Xin, X., Takamatsu, J.K., Saito, H., Ishikawa, Y., Akaza, T., Juji, T., Takebe, Y., Ohishi, T., Fukutake, K., Maruyama, Y., Yashiki, S., Sonoda, S., Nakamura, T., Nagai, Y., Iwamoto, A., and Shioda, T. (1999). Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression. Proc Natl Acad Sci USA 96, 4581-4585. (Pubitemid 29190379)
28. López-Maderuelo, D., Arnalich, F., Serantes, R., Gonzá lez, A., Codoceo, R., Madero, R., Vázquez, J.J., and Montiel, C. (2003). Interferon-gamma and interleukin-10 gene polymorphisms in pulmonary tuberculosis. Am J Respir Crit Care Med 167, 970-975. (Pubitemid 36408162)
29. Masood, E. (1999). As consortium plans free SNP map of human genome. Nature 398, 545-546.
30. McDermott, D.H., Beecroft, M.J., Kleeberger, C.A. Al-Sharif, F.M., Ollier, W.E., Zimmerman, P.A., Boatin, B.A., Leitman, S.F., Detels, R., Hajeer, A.H., and Murphy, P.M. (2000). Chemokine RANTES promoter polymorphism affects risk of both HIV infection and disease progression in the multicenter AIDS cohort study. Aids 14, 2671-2678. (Pubitemid 32118720)
31. Mö ller, M., and Hoal, E.G. (2010). Current findings, challenges and novel approaches in human genetic susceptibility to tuberculosis. Tuberculosis 90, 71-83.
32. Moriuchi, H., Moriuchi, M., and Fauci, A.S. (1997). Nuclear factor-kappa B potently up-regulates the promoter activity of RANTES, a chemokine that blocks HIV infection. J Immunol 158, 3483-3491. (Pubitemid 127484070)
33. Nelson, P.J., Kim, H.T., Manning, W.C., Goralski, T.J., and Krensky, A.M. (1993). Genomic organization and transcriptional regulation of the RANTES chemokine gene. J Immunol 151, 2601-2612. (Pubitemid 23264512)
34. Nelson, P.J., Ortiz, B.D., Pattison, J.M., and Krensky, A.M. (1996). Identification of a novel regulatory region critical for expression of the RANTES chemokine in activated T lymphocytes. J Immunol 157, 1139-1148.
35. Nickerson, D.A., Taylor, S.L., Weiss, K.M., Clark, A.G., Hutchinson, R.G., Stengard, J., Salomaa, V., Vartiainen, E., Boerwinkle, E., and Sing, C.F. (1998). DNA sequence diversity in a 9.7-kb region of the human lipoprotein lipase gene. Nat Genet 19, 233-240. (Pubitemid 28309333)
36. Risch, N., and Merikangas, K. (1996). The future of genetic studies of complex human diseases. Science 273, 1516-1517. (Pubitemid 26301653)
37. Roach, D.R., Bean, A.G., Demangel, C., France, M.P., Briscoe, ., and Britton, W.J. (2002). TNF regulates chemokine induction essential for cell recruitment, granuloma formation, and clearance of mycobacterial infection. J Immunol 168, 4620-4627. (Pubitemid 34441368)
38. Rodriguez, S., Gaunt, T.R., and Day I.N. (2009). Hardy-Weinberg equilibrium testing of biological ascertainment for Mendelian randomization studies. Am J Epidemiol 169, 505-514.
39. Roth, S.J., Carr, M.W., and Springer, T.A. (1995). C-C chemokines, but not the C-X-C chemokines, interleukin-8 and interferongamma inducible protein-10, stimulate transendothelial chemotaxis of T lymphocytes. Eur J Immunol 25, 3482-3488. (Pubitemid 26004958)
40. Sánchez-Castañó n, M., Baquero, I.C., Sánchez-Velasco, P., Fariñ as, M.C., Ausín, F., Leyva-Cobián, F., and Ocejo-Vinyals, J.G. (2009. Polymorphisms in CCL5 promoter are associated with pulmonary tuberculosis in northern Spain. Int J Tuberc Lung Dis 13, 480-485.
41. Saukkonen, J.J., Bazydlo, B., Thomas, M., Strieter, R.M., Keane, J., and Kornfeld, H. (2002). Beta-chemokines are induced by Mycobacterium tuberculosis and inhibit its growth. Infect Immun 70, 1684-1693. (Pubitemid 34242168)
42. Schall, T.J., Bacon, K., Toy, K.J., and Goeddel, D.V. (1990). Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature 347, 669-671. (Pubitemid 20356243)
43. Takada, T., Suzuki, E., Ishida, T., Moriyama, H., Ooi, H., asegawa, T., Tsukuda, H., and Gejyo, F. (2001). Polymorphism in RANTES chemokine promoter affects extent of sarcoidosis in a Japanese population. Tissue Antigens 58, 293-298. (Pubitemid 34095137)
44. Taub, D.D., Conlon, K., Lloyd, A.R., Oppenheim, J.J., and Kelvin, D.J. (1993). Preferential migration of activated CD4p and CD8p T cells in response to MIP-1 alpha and MIP-1 beta. Science 260, 355-358. (Pubitemid 23160144)
45. Taub, D.D., Turcovski-Corrales, S.M., Key, M.L, Longo, D.L., and Murphy, W.J. (1996). Chemokines and T lymphocytes activation: beta-chemokines costimulate human T lymphocyte activation in vitro. J Immunol 156, 2095-1103.
46. Tso, H.W., Ip, W.K., Chong, W.P., Tam, C.M., Chiang, A.K., and Lau, Y.L. (2005). Association of interferon gamma and interleukin 10 genes with tuberculosis in Hong Kong Chinese. Genes Immun 6, 358-363. (Pubitemid 40903409)
47. Vallinoto, A.C., Graça, E.S., Araú jo, M.S., Azevedo, V.N., Cayres-Vallinoto, I., Machado, L.F., Ishak, M.O., and Ishak, R. (2010). IFNG p874T/A polymorphism and cytokine plasma levels are associated with susceptibility to Mycobacterium tuberculosis infection and clinical manifestation of tuberculosis. Hum Immunol 71, 692-696.
48. World Health Organization (WHO) Report 2010a. Global tuberculosis control. WHO Report 2010b. Available at: www.emro.who.int/stb/pdf/ CountryProfile-tun-08.pdf (Accessed December 21, 2010).
49. WHO Report 2008. Tuberculosis. Available at: www.who.int/ mediacentre/factsheets/fs104/en/index.html (Accessed July 20, 2010).
50. Yao, T.C., Kuo, M.L., See, L.C., Chen, L.C., Yan, D.C., Ou, L.S., Shaw, C.K., and Huang, J.L. (2003). The RANTES promoter polymorphism: a genetic risk factor for near-fatal asthma in Chinese children. J Allergy Clin Immunol. 111, 1285-1292.
51. Yoshie, O., Imai, T., and Nomiyama, H. (2001). Chemokines in immunity. Adv Immunol 78, 57-110. (Pubitemid 32566018)
52. Zou, W., Borvak, J., Marches, F., Wei, S., Galanaud, P., Emilie, D., and Curiel, T.J. (2000). Macrophage-derived dendritic cells have strong Th1-polarizing potential mediated by betachemokines rather than IL-12. J Immunol 165, 4388-4396.